The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Nobivac Parvo-C

Intervet Ireland LimitedVPA10996/167/001

Main Information

Trade NameNobivac Parvo-C
Active SubstancesCanine parvovirus attenuated strain 154
Dosage FormLyophilisate and solvent for suspension for injection
Licence HolderIntervet Ireland Limited
License Holder AddressMagna Drive
Magna Business Park, Citywest Road
Dublin 24
Licence NumberVPA10996/167/001

Group Information

ATC CodeQI07AD01 canine parvovirus
Therapeutic ClassImmunological - Live Vaccine


License statusAuthorised
Licence Issued05/03/2004
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back